Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
02252
02252
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
02252 News
JPM: MEDBOT-B (02252.HK) Expands Internationally; Overweight Rating Maintained
3d ago
aastocks
JPM Maintains MEDBOT-B as Preferred Choice in China's Medical Technology Sector, Adjusts Price Target to HKD41
Jan 27 2026
aastocks
Study: Standardizing Service Pricing for CN Surgical Robots Enhances MEDBOT-B Commercialization Opportunities
Jan 22 2026
aastocks
MEDBOT-B Surges Over 5%; Projected Adjusted Loss for 2025 Anticipated to Decrease by Over 50%
Jan 22 2026
aastocks
Midday Update: HSI Ends at 26,447, Down 39 Points; HSTI at 5,691, Up 8 Points; ANTA SPORTS Falls Over 5%; BIDU-SW, MTR CORPORATION, SKYWORTH, TCL ELECTRONICS, and SINOTRUK Reach New Highs
Jan 21 2026
aastocks
MEDBOT-B Sees 30% Increase in Value with Surge in Trading Volume Following Registration Approval for Bronchoscopic Surgical Robot UniPath
Dec 29 2025
aastocks
JPM Identifies CN Healthcare Sector Decline as Buying Opportunity, Increases Price Targets for INNOVENT BIO and WUXI XDC
Dec 19 2025
aastocks
<Midday Update> HSI Ends Midday at 27,049, Decreasing by 237 Points; HSTI at 6,586, Down 96 Points; BYD COMPANY Falls Over 4%; SH ELECTRIC, CGN MINING, JIANGXI COPPER, MEDBOT-B, and BRILLIANCE CHI Reach New Peaks
Oct 03 2025
aastocks
Jefferies Raises MEDBOT-B (02252.HK) Price Target to $35; Order Growth Indicates Strong Outlook
Sep 05 2025
aastocks
<Daily Summary> HSI Ends at 25,343, Dropping 153 Points; HSTI Finishes at 5,683, Down 44 Points; BYD ELECTRONIC Falls Over 4%; CSPC PHARMA, CHOW TAI FOOK, MEDBOT-B, PA GOODDOCTOR, WUXI XDC Reach New Peaks; Market Turnover Increases
Sep 03 2025
aastocks
<Midday Update> HSI Ends Midday at 25,395, Down 101 Points; HSTI at 5,697, Down 31 Points; ZHONGSHENG HLDG Rises Over 4%; CSPC PHARMA, CHOW TAI FOOK, MEDBOT-B, PA GOODDOCTOR, and SIHUAN PHARM Reach New Highs
Sep 03 2025
aastocks
JPM Raises MEDBOT-B (02252.HK) Price Target to $30.9 and Upgrades Rating to Overweight
Sep 03 2025
aastocks
Citi Increases MEDBOT-B's Target Price to HKD32; Maintains Buy Rating
Sep 03 2025
aastocks
Show More News
